1 Autacoids and Related Drugs Market Overview 1.1 Product Overview and Scope of Autacoids and Related Drugs 1.2 Autacoids and Related Drugs Segment by Type 1.2.1 Global Autacoids and Related Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Polypeptides 1.2.3 Decarboxylated Amino Acids 1.2.4 Eicosanoids 1.3 Autacoids and Related Drugs Segment by Application 1.3.1 Global Autacoids and Related Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Allergies 1.3.3 Inflammation 1.3.4 Gastric Acid Secretion 1.3.5 Neuroendocrine Regulation 1.3.6 Chronic Pain 1.3.7 Cardiovascular Diseases 1.3.8 Gastrointestinal Diseases 1.4 Global Autacoids and Related Drugs Market Size Estimates and Forecasts 1.4.1 Global Autacoids and Related Drugs Revenue 2016-2027 1.4.2 Global Autacoids and Related Drugs Sales 2016-2027 1.4.3 Autacoids and Related Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Autacoids and Related Drugs Market Competition by Manufacturers 2.1 Global Autacoids and Related Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Autacoids and Related Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Autacoids and Related Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Autacoids and Related Drugs Manufacturing Sites, Area Served, Product Type 2.5 Autacoids and Related Drugs Market Competitive Situation and Trends 2.5.1 Autacoids and Related Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Autacoids and Related Drugs Players Market Share by Revenue 2.5.3 Global Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Autacoids and Related Drugs Retrospective Market Scenario by Region 3.1 Global Autacoids and Related Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Autacoids and Related Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Autacoids and Related Drugs Market Facts & Figures by Country 3.3.1 North America Autacoids and Related Drugs Sales by Country 3.3.2 North America Autacoids and Related Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Autacoids and Related Drugs Market Facts & Figures by Country 3.4.1 Europe Autacoids and Related Drugs Sales by Country 3.4.2 Europe Autacoids and Related Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Autacoids and Related Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Autacoids and Related Drugs Sales by Region 3.5.2 Asia Pacific Autacoids and Related Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Autacoids and Related Drugs Market Facts & Figures by Country 3.6.1 Latin America Autacoids and Related Drugs Sales by Country 3.6.2 Latin America Autacoids and Related Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Autacoids and Related Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Autacoids and Related Drugs Sales by Country 3.7.2 Middle East and Africa Autacoids and Related Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Autacoids and Related Drugs Historic Market Analysis by Type 4.1 Global Autacoids and Related Drugs Sales Market Share by Type (2016-2021) 4.2 Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Autacoids and Related Drugs Price by Type (2016-2021) 5 Global Autacoids and Related Drugs Historic Market Analysis by Application 5.1 Global Autacoids and Related Drugs Sales Market Share by Application (2016-2021) 5.2 Global Autacoids and Related Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Autacoids and Related Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Bedford Laboratories 6.1.1 Bedford Laboratories Corporation Information 6.1.2 Bedford Laboratories Description and Business Overview 6.1.3 Bedford Laboratories Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Bedford Laboratories Autacoids and Related Drugs Product Portfolio 6.1.5 Bedford Laboratories Recent Developments/Updates 6.2 Bristol-Myers Squibb 6.2.1 Bristol-Myers Squibb Corporation Information 6.2.2 Bristol-Myers Squibb Description and Business Overview 6.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bristol-Myers Squibb Autacoids and Related Drugs Product Portfolio 6.2.5 Bristol-Myers Squibb Recent Developments/Updates 6.3 Fresenius 6.3.1 Fresenius Corporation Information 6.3.2 Fresenius Description and Business Overview 6.3.3 Fresenius Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Fresenius Autacoids and Related Drugs Product Portfolio 6.3.5 Fresenius Recent Developments/Updates 6.4 Abbott Laboratories 6.4.1 Abbott Laboratories Corporation Information 6.4.2 Abbott Laboratories Description and Business Overview 6.4.3 Abbott Laboratories Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Abbott Laboratories Autacoids and Related Drugs Product Portfolio 6.4.5 Abbott Laboratories Recent Developments/Updates 6.5 Sanofi 6.5.1 Sanofi Corporation Information 6.5.2 Sanofi Description and Business Overview 6.5.3 Sanofi Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Sanofi Autacoids and Related Drugs Product Portfolio 6.5.5 Sanofi Recent Developments/Updates 6.6 AstraZeneca 6.6.1 AstraZeneca Corporation Information 6.6.2 AstraZeneca Description and Business Overview 6.6.3 AstraZeneca Autacoids and Related Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 AstraZeneca Autacoids and Related Drugs Product Portfolio 6.6.5 AstraZeneca Recent Developments/Updates 7 Autacoids and Related Drugs Manufacturing Cost Analysis 7.1 Autacoids and Related Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Autacoids and Related Drugs 7.4 Autacoids and Related Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Autacoids and Related Drugs Distributors List 8.3 Autacoids and Related Drugs Customers 9 Autacoids and Related Drugs Market Dynamics 9.1 Autacoids and Related Drugs Industry Trends 9.2 Autacoids and Related Drugs Growth Drivers 9.3 Autacoids and Related Drugs Market Challenges 9.4 Autacoids and Related Drugs Market Restraints 10 Global Market Forecast 10.1 Autacoids and Related Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Autacoids and Related Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Autacoids and Related Drugs by Type (2022-2027) 10.2 Autacoids and Related Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Autacoids and Related Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Autacoids and Related Drugs by Application (2022-2027) 10.3 Autacoids and Related Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Autacoids and Related Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Autacoids and Related Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Autacoids and Related Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Autacoids and Related Drugs Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Autacoids and Related Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Autacoids and Related Drugs Covered in This Study Table 5. Global Autacoids and Related Drugs Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Autacoids and Related Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Autacoids and Related Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Autacoids and Related Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Autacoids and Related Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Autacoids and Related Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Autacoids and Related Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Autacoids and Related Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autacoids and Related Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units) Table 16. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2021) Table 17. Global Autacoids and Related Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 19. North America Autacoids and Related Drugs Sales Market Share by Country (2016-2021) Table 20. North America Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Autacoids and Related Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 23. Europe Autacoids and Related Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Autacoids and Related Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Autacoids and Related Drugs Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Autacoids and Related Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Autacoids and Related Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Autacoids and Related Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 31. Latin America Autacoids and Related Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Autacoids and Related Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Autacoids and Related Drugs Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Autacoids and Related Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Autacoids and Related Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Autacoids and Related Drugs Sales (K Units) by Type (2016-2021) Table 39. Global Autacoids and Related Drugs Sales Market Share by Type (2016-2021) Table 40. Global Autacoids and Related Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Autacoids and Related Drugs Revenue Share by Type (2016-2021) Table 42. Global Autacoids and Related Drugs Price (USD/Pcs) by Type (2016-2021) Table 43. Global Autacoids and Related Drugs Sales (K Units) by Application (2016-2021) Table 44. Global Autacoids and Related Drugs Sales Market Share by Application (2016-2021) Table 45. Global Autacoids and Related Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Autacoids and Related Drugs Revenue Share by Application (2016-2021) Table 47. Global Autacoids and Related Drugs Price (USD/Pcs) by Application (2016-2021) Table 48. Bedford Laboratories Corporation Information Table 49. Bedford Laboratories Description and Business Overview Table 50. Bedford Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Bedford Laboratories Autacoids and Related Drugs Product Table 52. Bedford Laboratories Recent Developments/Updates Table 53. Bristol-Myers Squibb Corporation Information Table 54. Bristol-Myers Squibb Description and Business Overview Table 55. Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Bristol-Myers Squibb Autacoids and Related Drugs Product Table 57. Bristol-Myers Squibb Recent Developments/Updates Table 58. Fresenius Corporation Information Table 59. Fresenius Description and Business Overview Table 60. Fresenius Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Fresenius Autacoids and Related Drugs Product Table 62. Fresenius Recent Developments/Updates Table 63. Abbott Laboratories Corporation Information Table 64. Abbott Laboratories Description and Business Overview Table 65. Abbott Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Abbott Laboratories Autacoids and Related Drugs Product Table 67. Abbott Laboratories Recent Developments/Updates Table 68. Sanofi Corporation Information Table 69. Sanofi Description and Business Overview Table 70. Sanofi Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Sanofi Autacoids and Related Drugs Product Table 72. Sanofi Recent Developments/Updates Table 73. AstraZeneca Corporation Information Table 74. AstraZeneca Description and Business Overview Table 75. AstraZeneca Autacoids and Related Drugs Sales (K Units), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. AstraZeneca Autacoids and Related Drugs Product Table 77. AstraZeneca Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Autacoids and Related Drugs Distributors List Table 81. Autacoids and Related Drugs Customers List Table 82. Autacoids and Related Drugs Market Trends Table 83. Autacoids and Related Drugs Growth Drivers Table 84. Autacoids and Related Drugs Market Challenges Table 85. Autacoids and Related Drugs Market Restraints Table 86. Global Autacoids and Related Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 87. Global Autacoids and Related Drugs Sales Market Share Forecast by Type (2022-2027) Table 88. Global Autacoids and Related Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 89. Global Autacoids and Related Drugs Revenue Market Share Forecast by Type (2022-2027) Table 90. Global Autacoids and Related Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 91. Global Autacoids and Related Drugs Sales Market Share Forecast by Application (2022-2027) Table 92. Global Autacoids and Related Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 93. Global Autacoids and Related Drugs Revenue Market Share Forecast by Application (2022-2027) Table 94. Global Autacoids and Related Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 95. Global Autacoids and Related Drugs Sales Market Share Forecast by Region (2022-2027) Table 96. Global Autacoids and Related Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 97. Global Autacoids and Related Drugs Revenue Market Share Forecast by Region (2022-2027) Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Autacoids and Related Drugs Figure 2. Global Autacoids and Related Drugs Market Share by Type in 2020 & 2027 Figure 3. Polypeptides Product Picture Figure 4. Decarboxylated Amino Acids Product Picture Figure 5. Eicosanoids Product Picture Figure 6. Global Autacoids and Related Drugs Market Share by Application in 2020 & 2027 Figure 7. Allergies Figure 8. Inflammation Figure 9. Gastric Acid Secretion Figure 10. Neuroendocrine Regulation Figure 11. Chronic Pain Figure 12. Cardiovascular Diseases Figure 13. Gastrointestinal Diseases Figure 14. Global Autacoids and Related Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Autacoids and Related Drugs Market Size 2016-2027 (US$ Million) Figure 16. Global Autacoids and Related Drugs Sales 2016-2027 (K Units) Figure 17. Global Autacoids and Related Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Autacoids and Related Drugs Sales Share by Manufacturers in 2020 Figure 19. Global Autacoids and Related Drugs Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Autacoids and Related Drugs Players: Market Share by Revenue in 2020 Figure 21. Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2021) Figure 23. Global Autacoids and Related Drugs Sales Market Share by Region in 2020 Figure 24. Global Autacoids and Related Drugs Revenue Market Share by Region (2016-2021) Figure 25. Global Autacoids and Related Drugs Revenue Market Share by Region in 2020 Figure 26. U.S. Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Autacoids and Related Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Autacoids and Related Drugs by Type (2016-2021) Figure 51. Sales Market Share of Autacoids and Related Drugs by Application (2016-2021) Figure 52. Sales Market Share of Autacoids and Related Drugs by Application in 2020 Figure 53. Revenue Share of Autacoids and Related Drugs by Application (2016-2021) Figure 54. Revenue Share of Autacoids and Related Drugs by Application in 2020 Figure 55. Manufacturing Cost Structure of Autacoids and Related Drugs Figure 56. Manufacturing Process Analysis of Autacoids and Related Drugs Figure 57. Autacoids and Related Drugs Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Bedford Laboratories Bristol-Myers Squibb Fresenius Abbott Laboratories Sanofi AstraZeneca